Stockreport

Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024

Zevra Therapeutics, Inc.  (ZVRA) 
PDF CELEBRATION, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today annou [Read more]